Skip to main content
Caplight Logo









MedOrion

MedOrion

Private
Tel AvivHealthcare & Life Scienceshttps://medorion.com/

Last Round

Series A

Jul 7, 2021

Total Funding Raised

$9M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MedOrion is a healthcare technology company that provides a behavioral intelligence SaaS platform using AI and behavioral science to help health insurers personalize member engagement and improve health outcomes.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics, Vertical SaaS, InsurTech, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

member engagement platformbehavioral intelligenceMedicare AdvantageStar Ratings improvementStars optimizationhealthcare AIcare gap closurerisk adjustmentElectronic Behavioral RecordHEDIS improvementmedication adherencepayer solutionsvertical SaaSsocial determinants of healthSDOHRAF score optimizationEBRCAHPS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedOrion Comparables

Compare MedOrion with similar companies based on industry and business-model similarity.

MedOrion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Predict Health, Inc.
88%
Discovery Limited
85%
mPulse Mobile
79%

MedOrion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 7, 2021

Key People

Founding team and executive leadership

Eviatar Khen

Co Founder & CTO

Founding Team

Shai Levi

Co Founder & COO

Founding Team

Asaf Kleinbort

Co-Founder, CEO

Founding Team

MedOrion Investors

Notable investors and investment history

MedOrion investors
InvestorRounds
TAU VenturesSeed, Series A
Tau VenturesSeries A
10DSeries A
iAngelsSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 109% MoM, from 451 to 943.

  • Jul 20, 2026

    Open roles increased to 13, 31% of headcount.

MedOrion Filings

Explore SEC and related filing metadata, where available.

MedOrion filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MedOrion's valuation, stock price, and market status.

Is MedOrion a public or private company?

MedOrion is a private company.

What is the current stock price of MedOrion?

MedOrion is a private company with no public stock price. No recent secondary market data is available.

How much is MedOrion worth (valuation)?

Valuation information for MedOrion is not publicly available.

Can I buy MedOrion stock?

MedOrion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MedOrion's last funding round?

MedOrion's most recent funding round was Series A on July 7, 2021.

Who are the main investors in MedOrion?

Key investors in MedOrion include 10D.

Will MedOrion IPO soon?

No public IPO plans have been announced for MedOrion.

How can I track MedOrion secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MedOrion's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range34
Year Founded2017
Last FundingJul 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?